Treatment of Androgenic Disorders in Women: Acne, Hirsutism, and Alopecia

    Geoffrey P. Redmond, Wilma F. Bergfeld
    Image of study
    TLDR Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.
    Androgen excess disorders in women, including acne, alopecia, and hirsutism, were effectively treated with endocrine therapies such as androgen receptor blockers or antagonists, and androgen suppression. Spironolactone, estrogen, and dexamethasone were identified as the most effective treatments. Success depended on careful planning and recognizing that response rates varied among patients, with treatment typically continuing for at least 2 years.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community It’s over. NOTHING has worked.

      in Chat  95 upvotes 2 years ago
      A user who has been trying various treatments for hair loss for four years, with no success. Suggestions include use of minoxidil, finasteride, RU58841, microneedling, supplements and multivitamins, lifestyle changes, scalp biopsy, and SMP.

      community Wouldn’t this nuclear stack make it almost impossible to lose hair?

      in Research/Science  66 upvotes 4 months ago
      The conversation discusses a hair loss treatment regimen involving dutasteride, pyrilutamide, oral minoxidil, and microneedling, with the aim of suppressing DHT and stimulating hair growth. Users debate the effectiveness and potential side effects of these treatments, noting that individual results may vary and that no treatment is foolproof.

      community KX-826: Long-Term Safety Results are out!

      in Research/Science  163 upvotes 1 year ago
      KX-826 initially improves hair growth but declines after 24 weeks, with mild itching as a side effect. Combining it with minoxidil and finasteride may improve results, but long-term effectiveness is uncertain.

      community Binding affinity of pyrilutamide!

      in Update  167 upvotes 3 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.

      community Hair loss research is a money grab

      in Chat  217 upvotes 1 week ago
      Hair loss is linked to DHT, with treatments like finasteride and minoxidil being common but not definitive. Economic interests influence research, and there is potential for new treatments like PP405 and RU58841.

    Related Research

    7 / 7 results